- Home
- VIGL vs KNDI Comparison
VIGL vs KNDI Comparison
Compare VIGL & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- KNDI
- Stock Information
- Founded
- VIGL 2020
- KNDI 2002
- Country
- VIGL United States
- KNDI China
- Employees
- VIGL N/A
- KNDI N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- KNDI Auto Manufacturing
- Sector
- VIGL Health Care
- KNDI Consumer Discretionary
- Exchange
- VIGL Nasdaq
- KNDI Nasdaq
- Market Cap
- VIGL 134.9M
- KNDI 96.3M
- IPO Year
- VIGL 2022
- KNDI N/A
- Fundamental
- Price
- VIGL $7.99
- KNDI $1.13
- Analyst Decision
- VIGL Buy
- KNDI
- Analyst Count
- VIGL 7
- KNDI 0
- Target Price
- VIGL $8.00
- KNDI N/A
- AVG Volume (30 Days)
- VIGL 1.6M
- KNDI 97.2K
- Earning Date
- VIGL 08-12-2025
- KNDI 08-15-2025
- Dividend Yield
- VIGL N/A
- KNDI N/A
- EPS Growth
- VIGL N/A
- KNDI N/A
- EPS
- VIGL N/A
- KNDI N/A
- Revenue
- VIGL N/A
- KNDI $127,569,613.00
- Revenue This Year
- VIGL N/A
- KNDI N/A
- Revenue Next Year
- VIGL N/A
- KNDI N/A
- P/E Ratio
- VIGL N/A
- KNDI N/A
- Revenue Growth
- VIGL N/A
- KNDI 3.21
- 52 Week Low
- VIGL $1.31
- KNDI $0.89
- 52 Week High
- VIGL $8.00
- KNDI $2.12
- Technical
- Relative Strength Index (RSI)
- VIGL 88.87
- KNDI 48.38
- Support Level
- VIGL $7.86
- KNDI $1.06
- Resistance Level
- VIGL $7.96
- KNDI $1.16
- Average True Range (ATR)
- VIGL 0.02
- KNDI 0.07
- MACD
- VIGL -0.18
- KNDI 0.00
- Stochastic Oscillator
- VIGL 93.33
- KNDI 42.86
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.